Literature DB >> 7718418

Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment.

L Guillevin1, F Lhote.   

Abstract

The vasculitides are a heterogeneous group of disorders for which classification is needed to facilitate diagnosis and treatment. Recent studies based on a more comprehensive clinical analysis of symptoms and virologic investigations favor the recognition, in the polyarteritis nodosa (PAN) group, of a distinct form of systemic vasculitis called microscopic polyangiitis (MPA). This distinction may be confusing, so the features of each condition need to be more precisely defined. Differentiation between PAN and MPA cannot be based on only histologic criteria. Clinical manifestations (especially lung and kidney involvement), biologic signs (antineutrophil cytoplasmic antibodies and hepatitis B and C infection), and angiographic data must be taken into consideration. Therapeutic strategy should differ dramatically, depending on whether primary or secondary MPA or PAN has been diagnosed, and treatment optimization is certainly the best reason for improving the classification of the systemic vasculitides.

Entities:  

Mesh:

Year:  1995        PMID: 7718418

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  5 in total

1.  Methylprednisolone inhibits uptake of Ca2+ and Na+ ions into concanavalin A-stimulated thymocytes.

Authors:  F Buttgereit; S Krauss; M D Brand
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

2.  ANCA associated pauci-immune retinal vasculitis.

Authors:  M J Gallagher; K G-J Ooi; M Thomas; M Gavin
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

3.  Historical perspective of vasculitis: polyarteritis nodosa and microscopic polyangiitis.

Authors:  Eric L Matteson
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 4.  Corticosteroids for multiple sclerosis: I. Application for treating exacerbations.

Authors:  Elliot M Frohman; Anjali Shah; Eric Eggenberger; Luanne Metz; Robert Zivadinov; Olaf Stüve
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

5.  Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.

Authors:  Toshikazu Watanabe; Tomoyuki Minezawa; Midori Hasegawa; Yasuhiro Goto; Takuya Okamura; Yosuke Sakakibara; Yoshikazu Niwa; Atsushi Kato; Masamichi Hayashi; Sumito Isogai; Masashi Kondo; Naoki Yamamoto; Naozumi Hashimoto; Kazuyoshi Imaizumi
Journal:  BMC Pulm Med       Date:  2019-11-01       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.